Methylated Ccfdna from Plasma Biomarkers of Alzheimer’s Disease Using Targeted Bisulfite Sequencing

References

• Decker B , ShollLM. Cell-Free DNA Testing. In: Genomic MedicineSpringer, Cham, Switzerland, 41–54 (2020).
   Google Scholar
• Long JM , HoltzmanDM. Alzheimer disease: an update on pathobiology and treatment strategies. Cell179(2), 312–339 (2019).
   PubMed Web of Science ®Google Scholar
• Van De Haar HJ , BurgmansS , JansenJFAet al. Blood–brain barrier leakage in patients with early Alzheimer disease. Radiology281(2), 527–535 (2016).
   PubMed Web of Science ®Google Scholar
• Chakraborty A , DeWit NM , VanDer Flier WM , DeVries HE. The blood–brain barrier in Alzheimer’s disease. Vascul. Pharmacol.89, 12–18 (2017).
   PubMed Web of Science ®Google Scholar
• Noe CR , Noe-LetschnigM , HandschuhP , NoeCA , LanzenbergerR. Dysfunction of the blood–brain barrier – a key step in neurodegeneration and dementia. Front. Aging Neurosci.12, 185 (2020).
   PubMed Web of Science ®Google Scholar
• Zvěřová M . Clinical aspects of Alzheimer’s disease. Clin. Biochem.72, 3–6 (2019).
   PubMed Web of Science ®Google Scholar
• Octave JN . Alzheimer disease: cellular and molecular aspects. Bull. Mem. Acad. R. Med. Belg.160(10–12), 445–449 (2005).
   PubMedGoogle Scholar
• Pai MC , KuoYM , WangIF , ChiangPM , TsaiKJ. The role of methylated circulating nucleic acids as a potential biomarker in Alzheimer’s disease. Mol. Neurobiol.56(4), 2440–2449 (2019).
   PubMed Web of Science ®Google Scholar
• Stoccoro A , SicilianoG , MiglioreL , CoppedeF. Decreased methylation of the mitochondrial D-loop region in late-onset Alzheimer’s disease. J. Alzheimers Dis.59(2), 559–564 (2017).
   PubMed Web of Science ®Google Scholar
• Swarbrick S , WraggN , GhoshS , StolzingA. Systematic review of miRNA as biomarkers in Alzheimer’s disease. Mol. Neurobiol.56(9), 6156–6167 (2019).
   PubMed Web of Science ®Google Scholar
• Paraskevaidi M , AllsopD , KarimS , MartinFL , CreanS. Diagnostic biomarkers for Alzheimer’s disease using non-invasive specimens. J. Clin. Med.9(6), 1673 (2020).
   PubMed Web of Science ®Google Scholar
• Chen L . Cancer detection from plasma cell-free DNA. E3S Web Conf.218, 1–6 (2020).
   Google Scholar
• Duvvuri B , LoodC. Cell-free DNA as a biomarker in autoimmune rheumatic diseases. Front. Immunol.10, 502 (2019).
   PubMed Web of Science ®Google Scholar
• Robichaud PP , ArseneaultM , O’ConnellC , OuelletteRJ, Others. Circulating cell-free DNA as potential diagnostic tools for amyotrophic lateral sclerosis. Neurosci. Lett.750, 135813 (2021).
   PubMed Web of Science ®Google Scholar
• Snyder MW , KircherM , HillAJ , DazaRM , ShendureJ. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell164(1–2), 57–68 (2016).
   PubMed Web of Science ®Google Scholar
• Lehmann-Werman R , NeimanD , ZemmourHet al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl Acad. Sci. USA113(13), e1826–e1834 (2016).
   PubMed Web of Science ®Google Scholar
• Guo S , DiepD , PlongthongkumN , FungHL , ZhangK , ZhangK. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat. Genet.49(4), 635–642 (2017).
   PubMed Web of Science ®Google Scholar
• Moss J , MagenheimJ , NeimanDet al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun.9(1), 1–12 (2018).
   PubMedGoogle Scholar
• Cheng AP , ChengMP , GuWet al. Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity. Medicine (NY)2(4), 411–422 (2021).
   Google Scholar
• Constâncio V , NunesSP , HenriqueR , JerónimoC. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells9(3), 624 (2020).
   PubMed Web of Science ®Google Scholar
• Locke WJ , GuanzonD , MaCet al. DNA methylation cancer biomarkers: translation to the clinic. Front. Genet.10, 1150 (2019).
   PubMed Web of Science ®Google Scholar
• Luo H , WeiW , YeZ , ZhengJ , XuRH. Liquid biopsy of methylation biomarkers in cell-free DNA. Trends Mol. Med.27, 482–500 (2021).
   PubMed Web of Science ®Google Scholar
• Poon CH , TseLSR , LimLW. DNA methylation in the pathology of Alzheimer’s disease: from gene to cognition. Ann. NY Acad. Sci.1475(1), 15–33 (2020).
   PubMed Web of Science ®Google Scholar
• Roubroeks JAY , SmithRG , VanDen Hove DLA , LunnonK. Epigenetics and DNA methylomic profiling in Alzheimer’s disease and other neurodegenerative diseases. J. Neurochem.143, 158–170 (2017).
   PubMed Web of Science ®Google Scholar
• Qazi TJ , QuanZ , MirA , QingH. Epigenetics in Alzheimer’s disease: perspective of DNA methylation. Mol. Neurobiol.55(2), 1026–1044 (2018).
   PubMed Web of Science ®Google Scholar
• Coppedè F . Methylation analysis of DNA in Alzheimer’s disease. In: Genetics, Neurology, Behavior, and Diet in Dementia. Elsevier, Amsterdam, The Netherlands, 261–274 (2020).
   Google Scholar
• Chen L. , ShenQ. , XuS.et al. 5-hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for late-onset Alzheimer’s disease. J. Alzheimer Dis..85, 573–585 (2022).
   PubMed Web of Science ®Google Scholar
• Fransquet PD , RyanJ. The current status of blood epigenetic biomarkers for dementia. Crit. Rev. Clin. Lab. Sci.56(7), 435–457 (2019).
   PubMed Web of Science ®Google Scholar
• Gerber T , Taschner-MandlS , Saloberger-SindhöringerLet al. Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis. J. Mol. Diagn.22(8), 1070–1086 (2020).
   PubMed Web of Science ®Google Scholar
• Kustanovich A , SchwartzR , PeretzT , GrinshpunA. Life and death of circulating cell-free DNA. Cancer Biol. Ther.20(8), 1057–1067 (2019).
   PubMed Web of Science ®Google Scholar
• Sun K , JiangP , ChengSHet al. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin. Genome Res.29(3), 418–427 (2019).
   PubMed Web of Science ®Google Scholar
• Huang J , WangL. Cell-free DNA methylation profiling analysis – technologies and bioinformatics. Cancers (Basel)11(11), 1741 (2019).
   PubMed Web of Science ®Google Scholar
• Chan KCA , JiangP , ChanCWMet al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc. Natl Acad. Sci. U. S. A.110(47), 18761–18768 (2013).
   PubMed Web of Science ®Google Scholar
• Legendre C , GoodenGC , JohnsonK , MartinezRA , LiangWS , SalhiaB. Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer. Clin. Epigenetics7, 100 (2015).
   PubMed Web of Science ®Google Scholar
• Maggi EC , GravinaS , ChengHet al. Development of a method to implement whole-genome bisulfite sequencing of cfDNA from cancer patients and a mouse tumor model. Front. Genet.9, 6 (2018).
   PubMed Web of Science ®Google Scholar
• Erger F , NörlingD , BorchertDet al. cfNOMe – a single assay for comprehensive epigenetic analyses of cell-free DNA. Genome Med.12(1), 1–14 (2020).
   Web of Science ®Google Scholar
• Holmila R , SkliasA , MullerDCet al. Targeted deep sequencing of plasma circulating cell-free DNA reveals vimentin and fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma. PLoS One12(3), e0174265 (2017).
   PubMed Web of Science ®Google Scholar
• Xu RH , WeiW , KrawczykMet al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nat. Mater.16(11), 1155–1161 (2017).
   PubMed Web of Science ®Google Scholar
• Liu L , ToungJM , JassowiczAFet al. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification. Ann. Oncol.29(6), 1445–1453 (2018).
   PubMed Web of Science ®Google Scholar
• Liu MC , OxnardGR , KleinEAet al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol.31(6), 745–759 (2020).
   PubMed Web of Science ®Google Scholar
• Wu A , CremaschiP , WetterskogDet al. Genome-wide plasma DNA methylation features of metastatic prostate cancer. J. Clin. Invest.130(4), 1991–2000 (2020).
   PubMed Web of Science ®Google Scholar
• Wreczycka K , GosdschanA , YusufD , GrüningB , AssenovY , AkalinA. Strategies for analyzing bisulfite sequencing data. J. Biotechnol.261, 105–115 (2017).
   PubMed Web of Science ®Google Scholar
• Decamps C , PrivéF , BacherRet al. Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software. BMC Bioinformatics21(1), 1–15 (2020).
   PubMed Web of Science ®Google Scholar
• Davies MN , VoltaM , PidsleyRet al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol.13(6), R43 (2012).
   PubMed Web of Science ®Google Scholar
• Mauger F , HorguesC , Pierre-JeanM , OussadaN , MesrobL , DeleuzeJF. Comparison of commercially available whole-genome sequencing kits for variant detection in circulating cell-free DNA. Sci. Rep.10(1), 1–11 (2020).
   PubMed Web of Science ®Google Scholar
• Daviaud C , RenaultV , MaugerF , DeleuzeJF , TostJ. Whole-genome bisulfite sequencing using the Ovation® Ultralow Methyl-Seq protocol. Methods Mol. Biol.1708, 83–104 (2018).
   PubMedGoogle Scholar
• Martin M . Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J.17(1), 10–12 (2011).
   Google Scholar
• Krueger F , AndrewsSR. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics27(11), 1571–1572 (2011).
   PubMed Web of Science ®Google Scholar
• Quinlan AR , HallIM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics26(6), 841–842 (2010).
   PubMed Web of Science ®Google Scholar
• Akalin A , KormakssonM , LiSet al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol.13(10), 1–9 (2012).
   Web of Science ®Google Scholar
• Korthauer K , ChakrabortyS , BenjaminiY , IrizarryRA. Detection and accurate false discovery rate control of differentially methylated regions from whole genome bisulfite sequencing. Biostatistics20(3), 367–383 (2019).
   PubMed Web of Science ®Google Scholar
• Hahne F , IvanekR. Visualizing genomic data using Gviz and Bioconductor. Methods Mol. Biol.1418, 335–351 (2016).
   PubMedGoogle Scholar
• Harrow J , FrankishA , GonzalezJMet al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res.22(9), 1760–1774 (2012).
   PubMed Web of Science ®Google Scholar
• Cavalcante RG , SartorMA. Annotatr: genomic regions in context. Bioinformatics33(15), 2381–2383 (2017).
   PubMed Web of Science ®Google Scholar
• Uhlén M , FagerbergL , HallströmBMet al. Tissue-based map of the human proteome. Science347(6220), 120419 (2015).
   Web of Science ®Google Scholar
• Zhang L , SilvaTC , YoungJIet al. Epigenome-wide meta-analysis of DNA methylation differences in prefrontal cortex implicates the immune processes in Alzheimer’s disease. Nat. Commun.11(1), 1–13 (2020).
   PubMed Web of Science ®Google Scholar
• Lardenoije R , RoubroeksJAY , PishvaEet al. Alzheimer’s disease-associated (hydroxy)methylomic changes in the brain and blood. Clin. Epigenetics11(1), 1–15 (2019).
   PubMed Web of Science ®Google Scholar
• Semick SA , BharadwajRA , Collado-TorresLet al. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer’s disease. Acta Neuropathol.137(4), 557–569 (2019).
   PubMed Web of Science ®Google Scholar
• Watson CT , RoussosP , GargPet al. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer’s disease. Genome Med.8(1), 5 (2016).
   PubMedGoogle Scholar
• Roubroeks JAY , SmithAR , SmithRGet al. An epigenome-wide association study of Alzheimer’s disease blood highlights robust DNA hypermethylation in the HOXB6 gene. Neurobiol. Aging95, 26–45 (2020).
   PubMed Web of Science ®Google Scholar
• Madrid A , HoganKJ , PapaleLAet al. DNA hypomethylation in blood links B3GALT4 and ZADH2 to Alzheimer’s disease. J. Alzheimers Dis.66(3), 927–934 (2018).
   PubMed Web of Science ®Google Scholar
• Hernández HG , Sandoval-HernándezAG , Garrido-GilPet al. Alzheimer’s disease DNA methylome of pyramidal layers in frontal cortex: laser-assisted microdissection study. Epigenomics10(11), 1365–1382 (2018).
   PubMed Web of Science ®Google Scholar
• Roy A , Gonzalez-GomezM , PieraniA , MeyerG , ToleS. Lhx2 regulates the development of the forebrain hem system. Cereb. Cortex24(5), 1361–1372 (2014).
   PubMed Web of Science ®Google Scholar
• Yang H , KimJ , KimY , JangSW , SestanN , ShimS. Cux2 expression regulated by Lhx2 in the upper layer neurons of the developing cortex. Biochem. Biophys. Res. Commun.521(4), 874–879 (2020).
   PubMed Web of Science ®Google Scholar
• Srinivasan K , FriedmanBA , EtxeberriaAet al. Alzheimer’s patient microglia exhibit enhanced aging and unique transcriptional activation. Cell Rep.31(13), 107843 (2020).
   PubMed Web of Science ®Google Scholar
• Bouter Y , KacprowskiT , WeissmannRet al. Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer’s disease by deep sequencing. Front. Aging Neurosci.6, 75 (2014).
   PubMed Web of Science ®Google Scholar
• Strang KH , GoldeTE , GiassonBI. MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab. Invest.99(7), 912–928 (2019).
   PubMed Web of Science ®Google Scholar
• Pfeifer GP . Defining driver DNA methylation changes in human cancer. Int. J. Mol. Sci.19(4), 1166 (2018).
   PubMed Web of Science ®Google Scholar
• Anastasiadi D , Esteve-CodinaA , PiferrerF. Consistent inverse correlation between DNA methylation of the first intron and gene expression across tissues and species. Epigenetics Chromatin11(1), 1–17 (2018).
   PubMedGoogle Scholar
• Ozaki Y , YoshinoY , YamazakiKet al. DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer’s disease. J. Psychiatr. Res.92, 74–80 (2017).
   PubMed Web of Science ®Google Scholar
• Gu J , BarreraJ , YunYet al. Cell-type specific changes in DNA methylation of SNCA intron 1 in synucleinopathy brains. Front. Neurosci.15, 493 (2021).
   Web of Science ®Google Scholar
• Shao Y , ShawM , ToddKet al. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer’s disease. J. Hum. Genet.63(4), 459–471 (2018).
   PubMed Web of Science ®Google Scholar
• Dor Y , CedarH. Principles of DNA methylation and their implications for biology and medicine. Lancet392(10149), 777–786 (2018).
   PubMed Web of Science ®Google Scholar
• Wu J , DaiW , WuL , LiW , XiaX , WangJ. Decoding genetic and epigenetic information embedded in cell free DNA with adapted SALP-seq. Int. J. Cancer145(9), 2395–2406 (2019).
   PubMed Web of Science ®Google Scholar
• Chen X , WuT , LiLet al. Transcriptional start site coverage analysis in plasma cell-free DNA reveals disease severity and tissue specificity of COVID-19 patients. Front. Genet.12, 663098 (2021).
   PubMed Web of Science ®Google Scholar
• Barefoot ME , LoyferN , KilitiAJ , McDeedAP 4th , KaplanT , WellsteinA. Detection of cell types contributing to cancer from circulating, cell-free methylated DNA. Front. Genet.12, 671057 (2021).
   PubMed Web of Science ®Google Scholar
• Chatterton Z , MendelevN , ChenSet al. Brain-derived circulating cell-free DNA defines the brain region and cell specific origins associated with neuronal atrophy. bioRxiv538827, 538827 (2019).
   Google Scholar
• Chatterton Z , MendelevN , ChenSet al. Bisulfite amplicon sequencing can detect glia and neuron cell-free DNA in blood plasma. Front. Mol. Neurosci.14, 672614 (2021).
   PubMed Web of Science ®Google Scholar
• Bailleux C , LacroixL , BarrangerE , DelalogeS. Using methylation signatures on cell-free DNA for early cancer detection: a new era in liquid biopsy?Ann. Oncol.31(6), 665–667 (2020).
   PubMed Web of Science ®Google Scholar
• Bruno DCF , DonattiA , MartinMet al. Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders. Braz. J. Med. Biol. Res.53(10), e9881 (2020).
   PubMed Web of Science ®Google Scholar
• Wang DS , BennettDA , MufsonEJ , MattilaP , CochranE , DicksonDW. Contribution of changes in ubiquitin and myelin basic protein to age-related cognitive decline. Neurosci. Res.48(1), 93–100 (2004).
   PubMed Web of Science ®Google Scholar
• Zhan X , JicklingGC , AnderBPet al. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer’s disease brain. J. Alzheimers Dis.44(4), 1213–1229 (2015).
   PubMed Web of Science ®Google Scholar
• Papuć E , RejdakK. The role of myelin damage in Alzheimer’s disease pathology. Arch. Med. Sci.16(2), 345 (2020).
   PubMed Web of Science ®Google Scholar
• Sanchez-Mut JV , AsoE , HeynHet al. Promoter hypermethylation of the phosphatase DUSP22 mediates PKA-dependent TAU phosphorylation and CREB activation in Alzheimer’s disease. Hippocampus24(4), 363–368 (2014).
   PubMed Web of Science ®Google Scholar